139 related articles for article (PubMed ID: 12795658)
1. Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B.
Schiekofer S; Rudofsky G; Andrassy M; Schneider J; Chen J; Isermann B; Kanitz M; Elsenhans S; Heinle H; Balletshofer B; Häring HU; Schleicher E; Nawroth PP; Bierhaus A
Diabetes Obes Metab; 2003 Jul; 5(4):251-61. PubMed ID: 12795658
[TBL] [Abstract][Full Text] [Related]
2. Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes.
Schiekofer S; Galasso G; Andrassy M; Aprahamian T; Schneider J; Rocnik E
Diabetes Obes Metab; 2006 Sep; 8(5):473-82. PubMed ID: 16918581
[TBL] [Abstract][Full Text] [Related]
3. Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.
Jojima T; Suzuki K; Hirama N; Uchida K; Hattori Y
Diabetes Obes Metab; 2009 Feb; 11(2):143-9. PubMed ID: 18564176
[TBL] [Abstract][Full Text] [Related]
4. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
5. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
Rudofsky G; Reismann P; Grafe IA; Konrade I; Djuric Z; Tafel J; Buchbinder S; Zorn M; Humpert PM; Hamann A; Morcos M; Nawroth PP; Bierhaus A
Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974
[TBL] [Abstract][Full Text] [Related]
6. Postprandial mononuclear NF-kappaB activation is independent of the AGE-content of a single meal.
Schiekofer S; Franke S; Andrassy M; Chen J; Rudofsky G; Schneider JG; von Eynatten M; Wendt T; Morcos M; Kientsch-Engel R; Stein G; Schleicher E; Nawroth PP; Bierhaus A
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):160-7. PubMed ID: 16705547
[TBL] [Abstract][Full Text] [Related]
7. Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs.
Rudofsky G; Reismann P; Schiekofer S; Petrov D; von Eynatten M; Humpert PM; Isermann B; Müller-Hoff C; Thai TP; Lichtenstein S; Bärtsch U; Hamann A; Nawroth P; Bierhaus A
Horm Metab Res; 2004 Sep; 36(9):630-8. PubMed ID: 15486815
[TBL] [Abstract][Full Text] [Related]
8. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease.
Thiele K; Bierhaus A; Autschbach F; Hofmann M; Stremmel W; Thiele H; Ziegler R; Nawroth PP
Gut; 1999 Nov; 45(5):693-704. PubMed ID: 10517905
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-mediated decrease of the redox-sensitive transcription factor NF-kappaB is inversely correlated with the hemoglobin level.
Andrassy M; Bierhaus A; Hong M; Sis J; Schiekofer S; Humper PM; Chen J; Haap M; Renn W; Schleicher E; Häring HU; Andrassy K; Nawroth PP
Clin Nephrol; 2002 Sep; 58(3):179-89. PubMed ID: 12357990
[TBL] [Abstract][Full Text] [Related]
11. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs.
Schiekofer S; Andrassy M; Chen J; Rudofsky G; Schneider J; Wendt T; Stefan N; Humpert P; Fritsche A; Stumvoll M; Schleicher E; Häring HU; Nawroth PP; Bierhaus A
Diabetes; 2003 Mar; 52(3):621-33. PubMed ID: 12606501
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
Luis Bautista J; Bugos C; Dirnberger G; Atherton T
Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
[TBL] [Abstract][Full Text] [Related]
13. Activation of tubular epithelial cells in diabetic nephropathy.
Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
[TBL] [Abstract][Full Text] [Related]
14. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
Langtry HD; Balfour JA
Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
[TBL] [Abstract][Full Text] [Related]
15. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
16. High glucose-induced NF-kappaB activation occurs via tyrosine phosphorylation of IkappaBalpha in human glomerular endothelial cells: involvement of Syk tyrosine kinase.
Yang WS; Seo JW; Han NJ; Choi J; Lee KU; Ahn H; Lee SK; Park SK
Am J Physiol Renal Physiol; 2008 May; 294(5):F1065-75. PubMed ID: 18353872
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise on cyclooxygenase-2 expression and nuclear factor-kappaB DNA binding in human peripheral blood mononuclear cells.
Kim SY; Jun TW; Lee YS; Na HK; Surh YJ; Song W
Ann N Y Acad Sci; 2009 Aug; 1171():464-71. PubMed ID: 19723090
[TBL] [Abstract][Full Text] [Related]
18. [Regulatory effects of lanthanum chloride on the activation of nuclear factor kappa B inhibitor kinase beta induced by tumor necrosis factor alpha].
Guo F; He F; Xiu M; Lou YL; Xie A; Liu F; Li GH
Zhonghua Shao Shang Za Zhi; 2013 Dec; 29(6):531-6. PubMed ID: 24495640
[TBL] [Abstract][Full Text] [Related]
19. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha.
Dichamp I; Bourgeois A; Dirand C; Herbein G; Wendling D
J Rheumatol; 2007 Oct; 34(10):1976-83. PubMed ID: 17896809
[TBL] [Abstract][Full Text] [Related]
20. Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: randomized controlled trial (PioRAGE).
Koyama H; Tanaka S; Monden M; Shoji T; Morioka T; Fukumoto S; Mori K; Emoto M; Shoji T; Fukui M; Fujii H; Nishizawa Y; Inaba M
Atherosclerosis; 2014 Jun; 234(2):329-34. PubMed ID: 24727234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
